This site contains research compounds intended for laboratory and research use only. Please confirm you are 21 or older and agree to our research-use terms.
I am under 21 / exitFor research use only. Not for human consumption.
Wolverine is a co-lyophilized research blend of BPC-157 (10 mg) and TB-500 (10 mg). HPLC-verified at ≥99% purity with a batch-specific certificate of analysis on every lot.
Per vial, with 20% Fall Sale discount already applied.
Choose quantity
View the 20 MG lab certificate (PDF)Wolverine pairs two peptides that are normally studied separately — BPC-157 and TB-500 — co-lyophilized in a single 20 mg vial at 10 mg each.
BPC-157 is a 15-amino-acid sequence derived from a protein found in gastric juice. TB-500 is a thymosin β4 peptide (CAS 77591-33-4), associated with actin binding. The two are structurally unrelated and act through different mechanisms, which is why they are studied as a pair rather than as a single molecule.
Co-lyophilisation matters practically: both peptides reconstitute from one vial in one step, so the ratio between them is fixed at manufacture rather than by pipetting two separate stocks. Nothing on this page should be read as a claim that the combination produces any particular result.
A 15-amino-acid peptide (a pentadecapeptide) derived from a sequence identified in gastric juice. CAS 137525-51-0. Supplied here at 10 mg per vial, HPLC-verified to ≥99%.
A thymosin β4 peptide, CAS 77591-33-4, associated with actin binding. Supplied here at 10 mg per vial, HPLC-verified to ≥99%.
The references below concern the individual components, not this blend. Both peptides have been studied principally in animal models; neither is an approved drug, and the BPC-157 + TB-500 combination has not been evaluated as a combination in published clinical trials. They are cited as literature — APEX 100 Research makes no claim about outcomes, efficacy or suitability for any purpose.
Volume pricing applies automatically at checkout.
Prices shown include the 20% Fall Sale discount.

One 20 mg vial containing BPC-157 (10 mg) and TB-500 (10 mg), co-lyophilized together. Catalogue
SKU A100-BB20.
High-performance liquid chromatography separates the sample into its components and measures each as a proportion of the total. ≥99% means the target peptide accounts for at least 99% of the material by that method. The chromatogram showing this is included in the lot’s COA.
Yes. Sample documentation is on our COA page, and we will send the specific COA for any lot on request — before or after purchase.
No. This material is supplied strictly as a research material. It is not a drug product and is not for human consumption.
Sourced and shipped within the United States, typically 2-day delivery. Lyophilized peptides are stable in transit; refrigerate on arrival.
They are co-lyophilized, so the 10 mg : 10 mg ratio is fixed at manufacture and both reconstitute in a single step. It removes the pipetting error involved in combining two separate stocks.
Every lot is tested before release and ships with its own certificate of analysis. We publish the COA unredacted — including the lot number, the test date and the actual chromatogram — rather than a summary figure.
High-performance liquid chromatography establishes purity against the ≥99% specification. The chromatogram is included in the COA, not just the resulting number.
Identity is confirmed by mass spectrometry against the expected molecular weight of each component (BPC-157 1419.556 g/mol; TB-500 4963 g/mol).
Each vial’s lot number corresponds to a specific COA on file. Request the document for any lot you have received at any time.
| Blend | Wolverine — BPC-157 10 mg + TB-500 10 mg, co-lyophilized (20 mg total) |
|---|---|
| Component 1 | BPC-157 — pentadecapeptide, 15 amino acids |
| BPC-157 CAS | 137525-51-0 |
| BPC-157 formula | C62H98N16O22 |
| BPC-157 molecular weight | 1419.556 g/mol |
| Component 2 | TB-500 — thymosin β4 peptide |
| TB-500 formula | C212H350N56O78S |
| TB-500 molecular weight | 4963 g/mol |
| TB-500 CAS | 77591-33-4 |
| Physical form | Lyophilized powder, white to off-white |
| Purity | ≥99% by HPLC |
| Identity confirmation | Mass spectrometry |
| Vial size | 20 mg (SKU A100-BB20) |
| Storage | Lyophilized: 36–46 °F. Long term: −4 °F, protected from light |
| Documentation | Batch-specific COA, unredacted, retained on file per lot |
Supplied lyophilized. Standard laboratory handling for peptides of this class applies.
| Lyophilized storage | 36–46 °F short term; −4 °F for extended storage, protected from light |
|---|---|
| Reconstitution | Bacteriostatic water is the common choice for laboratory reconstitution. Add solvent slowly against the vial wall; do not inject directly onto the powder. |
| Mixing | Swirl gently until dissolved. Do not shake or vortex — mechanical agitation can shear peptide chains. |
| After reconstitution | Refrigerate at 36–46 °F. Avoid repeated freeze-thaw cycles. |
| Light | Protect from light at all stages. |
These are general laboratory handling notes for a lyophilized peptide. They are not a protocol, and nothing on this page constitutes a dosing recommendation of any kind.
Research use only. Not for human consumption.
All materials supplied by APEX 100 Research are intended exclusively for laboratory research by qualified professionals. They are not drugs, foods, cosmetics, or medical devices, and they are not intended to diagnose, treat, cure or prevent any disease or condition.
Nothing on this page is medical advice, a dosing recommendation, or a representation that this compound is safe or effective for any purpose. Wolverine is an investigational compound that has not been approved for any use by the FDA or any comparable regulatory authority. Peer-reviewed publications are referenced above so researchers may consult the primary literature directly; their citation is not a claim about this material.
By purchasing, the buyer confirms they are a qualified researcher, are 21 years of age or older, and accept full responsibility for lawful handling, storage and use of the material.